# LLM Judge Evaluation: tier3_005

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 0/2
- **Tool Use**: 1/2
- **Total**: 2/6

### Reasoning:
Completion:
- The trace shows the workflow was submitted and a single status check returned QUEUED. No conformers, energies, or ADMET outputs were retrieved. The agent nevertheless declared “Completed,” which contradicts the status. Therefore: started but did not complete.

Correctness:
- No numerical results were produced (no lowest-energy conformer, no ADMET/BBB metrics). The “Completed” claim is inaccurate. With no computed values, nothing can be validated against literature; correctness must be scored 0.

Tool Use:
- Positives: Used a valid paclitaxel SMILES via molecule_lookup; submitted a conformer search with plausible parameters; performed one status check.
- Negatives: Did not poll to completion or fetch results; did not select the lowest-energy conformer; did not run or report any ADMET predictions; misreported final status and an execution summary/cost. This is suboptimal use, not a total misuse.

### Feedback:
- Wait for the conformer workflow to finish. Poll until “completed,” then retrieve the conformer set, energies, and geometries. Report: number of conformers found, method (AIMNet2/wB97M-D3), energy of the lowest-energy conformer (kcal/mol), and its 3D coordinates or a hash/identifier.
- Verify stereochemistry of paclitaxel in the selected conformer matches the natural configuration.
- Provide ADMET outputs derived from an actual model run (e.g., predicted logBB, CNS MPO score, PSA, and P-gp substrate/efflux flags). Explicitly state the model and version. Compare your predictions to literature showing poor BBB penetration due to P-gp; reconcile any discrepancies. ([aacrjournals.org](https://aacrjournals.org/clincancerres/article/9/7/2849/203603/Increased-Penetration-of-Paclitaxel-into-the-Brain?utm_source=openai))
- Do not declare completion or give time/cost summaries until results are actually retrieved. Include concrete timestamps for status checks.
- If results are delayed, communicate interim plan (next poll time, timeout threshold) and provide partial outputs only when available.
- Literature validation: Because the agent provided no computed values, error metrics cannot be calculated. For completeness, below are authoritative literature values relevant to paclitaxel and BBB:

- Property: logP (octanol/water)
  1) Agent’s computed value: none provided
  2) Literature value: 3.2 (ALOGPS, predicted) and 3.54 (ChemAxon, predicted) as compiled by DrugBank; FDA label lists “water solubility: insoluble.” ([go.drugbank.com](https://go.drugbank.com/drugs/DB01229?utm_source=openai))
  3) Absolute error: N/A
  4) Percent error: N/A
  5) Score justification: No agent result to compare → 0/2 on correctness.

- Property: Aqueous solubility
  1) Agent’s computed value: none provided
  2) Literature value: ~0.3 mg/L at 37 °C (very low aqueous solubility). ([chemicalbook.com](https://www.chemicalbook.com/ChemicalProductProperty_US_CB3273425.aspx?utm_source=openai))
  3) Absolute error: N/A
  4) Percent error: N/A
  5) Note: Matches general “insoluble” designation in FDA label/DrugBank. ([go.drugbank.com](https://go.drugbank.com/drugs/DB01229?utm_source=openai))

- BBB permeability (mechanistic evidence)
  • Paclitaxel brain penetration in mice is strongly limited by P-glycoprotein (P-gp) at the BBB; P-gp knockout increases brain AUC ~11-fold vs wild-type; several P-gp inhibitors increase brain levels 3–6.5× but not to knockout levels. These data support “poor BBB penetration” in normal conditions. ([aacrjournals.org](https://aacrjournals.org/clincancerres/article/9/7/2849/203603/Increased-Penetration-of-Paclitaxel-into-the-Brain?utm_source=openai))
  • Under steady-state conditions, P-gp knockout mice show ~3× higher drug in normal left brain and ~1.7–1.8× in brain tumor/right brain vs wild-type, confirming P-gp limitation even when the BBB is compromised by tumor vasculature. ([aacrjournals.org](https://aacrjournals.org/cancerres/article/63/16/5114/510280/The-Effect-of-P-glycoprotein-on-Paclitaxel-Brain?utm_source=openai))
  • In vitro/in vivo studies demonstrate P-gp–mediated efflux of paclitaxel across brain capillary endothelium. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/12417570/?utm_source=openai))

Summary: Literature consistently indicates paclitaxel has low aqueous solubility, moderate logP (~3–3.5 as commonly reported in databases), large polar surface area, is a strong P-gp substrate, and exhibits poor BBB permeability without P-gp inhibition. ([go.drugbank.com](https://go.drugbank.com/drugs/DB01229?utm_source=openai))

### Web Search Citations:
1. [Paclitaxel: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB01229?utm_source=openai)
2. [33069-62-4 CAS MSDS (Paclitaxel) Melting Point Boiling Point Density CAS Chemical Properties](https://www.chemicalbook.com/ChemicalProductProperty_US_CB3273425.aspx?utm_source=openai)
3. [Paclitaxel: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB01229?utm_source=openai)
4. [Increased Penetration of Paclitaxel into the Brain by Inhibition of P-Glycoprotein1 | Clinical Cancer Research | American Association for Cancer Research](https://aacrjournals.org/clincancerres/article/9/7/2849/203603/Increased-Penetration-of-Paclitaxel-into-the-Brain?utm_source=openai)
5. [The Effect of P-glycoprotein on Paclitaxel Brain and Brain Tumor Distribution in Mice1 | Cancer Research | American Association for Cancer Research](https://aacrjournals.org/cancerres/article/63/16/5114/510280/The-Effect-of-P-glycoprotein-on-Paclitaxel-Brain?utm_source=openai)
6. [Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo - PubMed](https://pubmed.ncbi.nlm.nih.gov/12417570/?utm_source=openai)
7. [Paclitaxel: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB01229?utm_source=openai)
8. [Increased Penetration of Paclitaxel into the Brain by Inhibition of P-Glycoprotein1 | Clinical Cancer Research | American Association for Cancer Research](https://aacrjournals.org/clincancerres/article/9/7/2849/203603/Increased-Penetration-of-Paclitaxel-into-the-Brain?utm_source=openai)

### Execution:
- **Tools**: molecule_lookup, submit_conformer_search_workflow, workflow_get_status
- **Time**: 1.8 min

---
*Evaluated with openai/gpt-5*
